Polaris Market Research today announced findings from its latest report, projecting the global U.S. Artificial Ventilation and Anesthesia Masks market to grow from USD 540.73 Million in 2024 to USD 837.72 Million by 2034, at a CAGR of 4.5%. The report profiles 10 leading companies across 2 market segments.

Artificial ventilation and anesthesia masks are essential medical devices used to deliver oxygen and anesthetic gases while supporting patient breathing during surgery, emergencies, or long-term respiratory care. These devices come in a range of designs to fit different patient needs and clinical settings, and ongoing innovation is focused on improving comfort, sealing performance, and ease of gas delivery through lighter materials and more ergonomic shapes.

Analyst Commentary on U.S. Artificial Ventilation and Anesthesia Masks Market Growth

"Rising surgical volumes and an aging population continue to sustain steady demand for ventilation and anesthesia masks across U.S. healthcare settings," said a senior analyst at Polaris Market Research. "Buyers evaluating market entry should note the growing shift toward reusable, sustainability-focused mask designs."

Key Growth Drivers, Major Companies and Segments Covered

Growth Drivers: Growing number of surgical procedures and rising prevalence of chronic respiratory diseases are the primary forces behind the market's expansion, alongside growing healthcare expenditure and demand for advanced, better-sealing mask designs.

According to the Healthcare Cost and Utilization Project (HCUP), U.S. hospital-owned facilities recorded 11.9 million encounters for major ambulatory surgeries in 2019, and the CDC estimated that 6.5% of U.S. adults, or about 14.2 million people, had physician-diagnosed COPD in 2021 — both underscoring sustained demand for anesthesia and ventilation support.

By mask type, disposable masks led in 2024 due to their infection-control benefits, convenience, and cost-effectiveness in eliminating cleaning and sterilization steps, while reusable masks are expected to grow fastest as hospitals pursue sustainability goals and long-term cost savings. By application, operating rooms held the largest share given the consistent need for precise anesthesia delivery during surgery, while Ambulatory Surgical Centers (ASCs) are set to expand quickly as more procedures shift to outpatient settings.

Major Companies Covered: 

• Ambu A/S
• Drägerwerk AG & Co. KGaA
• Fisher & Paykel Healthcare Corporation Limited
• Getinge AB
• Hamilton Medical AG (Hamilton Company)
• Koninklijke Philips N.V. (Philips Healthcare)
• Medtronic PLC
• ResMed Inc.

Segments Covered: By Mask (Disposable Masks, Reusable Masks), By Application (Operating Rooms, ICU, Emergency Rooms, Homecare, ASCs).

Browse In-depth Market Research Report:

https://www.polarismarketresearch.com/industry-analysis/us-artificial-ventilation-and-anesthesia-masks-market 

Recent Developments in the U.S. Artificial Ventilation and Anesthesia Masks Market

• March 2025: Fisher & Paykel Healthcare launched the F&P Nova Nasal mask in New Zealand and Australia.
• February 2025: Teleflex Incorporated launched a next-generation anesthesia mask featuring integrated oxygen delivery monitoring sensors for outpatient and emergency use.
• April 2024: Fisher & Paykel Healthcare launched its F&P Solo™ Nasal mask for obstructive sleep apnea in the United States.

Segment Snapshot: Disposable Masks Lead, ASCs Fastest-Growing

Disposable masks held the largest share in 2024, driven by infection-control benefits and cost-effectiveness across hospitals and clinics, while Ambulatory Surgical Centers (ASCs) are anticipated to post the fastest growth as outpatient procedure volumes rise and healthcare systems seek lower-cost alternatives to traditional inpatient surgery.

Why It Matters for Teams Evaluating Market Entry

For stakeholders researching teams evaluating market entry, the underlying report benchmarks u.s. artificial ventilation and anesthesia masks market share, company positioning, and segment-level forecasts to support sourcing, partnership, and investment decisions through 2034.

Conclusion

The U.S. artificial ventilation and anesthesia masks market is set for steady, if unspectacular, growth through 2034, anchored by durable demand drivers including an aging population, a high volume of surgical procedures, and rising chronic respiratory disease prevalence. At the same time, the competitive landscape is shifting: sustainability pressure is pushing providers toward reusable mask formats, while manufacturers such as Teleflex and Fisher & Paykel Healthcare are embedding smarter monitoring features into next-generation designs. For companies assessing supplier relationships, product development priorities, or market entry, the combination of stable clinical demand and accelerating design innovation makes this a market worth tracking closely over the next decade.

More Trending Latest Reports By Polaris Market Research:

Garden Seeds Market

Flow Computer in Oil & Gas Market

Cardamom Oil Market

A Comprehensive Guide to the Stable Isotope Labeled Compounds Market

Asia Pacific Steam Turbine Market

Asia Pacific Steam Turbine Market

Semiconductor Memory Market

Viral Sensitizers Market

Ultra-Fine Aluminum Hydroxide Market